Partner Article
Winsford’s surgical company AMS report pre-tax profit up 16%
Winsford’s surgical and advanced wound-care company, Advanced Medical Solutions Group plc (AMS), reported profit up 16% at £15.2 million.
The company has also agreed a new five year £30 million multi-currency revolving credit facility.
AMS report strong revenue growth across the board with particular success in the USA.
Chief executive officer of AMS, Chris Meredith, said: “2014 has been another year of good growth for AMS, with our three largest business units all delivering solid performances despite challenging currency conditions.
“We were particularly encouraged by strong growth in the US, where the performance, range and pricing of our LiquiBand tissue adhesives is helping to drive gains in market share, and in the UK, where the ActivHeal range continues to provide high performance, cost effective solutions for the NHS.
“The successful launch of the LiquiBand Fix8 hernia mesh fixation device, marking the first use of our medical adhesives in internal applications, demonstrates our continued commitment to investing in innovation.
“With the continuing growth in our larger business units, the strong performance of our products and our ambitions for the Group, we are confident that AMS is well placed to drive growth as well as continued improvements in operational efficiencies and we remain excited by the prospects for our future.”
This was posted in Bdaily's Members' News section by Sophia Taha .
The true value of HR in an AI-driven working world
What new business rates guidance means for pubs
Business success starts with people investment
It's time to confront the digital poverty crisis
Why a business exit is no longer all or nothing
Culture is the foundation for sustainable growth
Business must help young people take root in work
Purposeful procurement for long-term growth
Time to rethink outdated views on apprenticeships
The scale-ups rocketing through our fast world
Care about the experience, not just the outcome
The rise of an alternative investor model